Wendy Liu

Wendy Liu is a seasoned professional with extensive experience in business development and board leadership across various organizations. Currently, Wendy holds the position of Principal at Plaisance Capital Management LLC since January 2022 and serves as a Board Observer for multiple companies, including Reunion Neuroscience, BlossomHill Therapeutics, Corsair Pharma, Cephla, and Smartlens. Additionally, Wendy is a Board Member for Green Agro and ProteoValent Therapeutics, where Wendy also serves as Interim Chief Operations Officer. Prior to these roles, Wendy gained valuable experience at WuXi AppTec from June 2018 to December 2021, where Wendy progressed from Manager to Director of Business Development, focusing on managing a client portfolio and securing business opportunities in the Northeast US. Wendy's background includes a Ph.D. from Georgia Institute of Technology, a Master's degree from Washington University in St. Louis, and a Bachelor's degree in Chemical Engineering from Tianjin University.